Literature DB >> 16556096

Sildenafil citrate for the treatment of pulmonary arterial hypertension.

Sabina A Antoniu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16556096     DOI： 10.1517/14656566.7.6.825

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


× No keyword cloud information.
  5 in total

1.  Population pharmacokinetic model of the pregabalin-sildenafil interaction in rats: application of simulation to preclinical PK-PD study design.

Authors:  Gregor Bender; James Gosset; Jeff Florian; Keith Tan; Mark Field; Scott Marshall; Joost DeJongh; Robert Bies; Meindert Danhof
Journal:  Pharm Res       Date:  2009-08-11       Impact factor: 4.200

2.  The role of sildenafil in the development of transplant arteriosclerosis in rat aortic grafts.

Authors:  Shuai Luo; Mei Yang; Hao Jin; Zi-Qiang Xu; Yi-Fu Li; Peng Xia; Yi-Rrong Yang; Bi-Cheng Chen; Yan Zhang
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 3.  Sildenafil for the treatment of pulmonary hypertension in pediatric patients.

Authors:  Alice J Huddleston; Chad A Knoderer; Jennifer L Morris; Eric S Ebenroth
Journal:  Pediatr Cardiol       Date:  2009-08-25       Impact factor: 1.655

Review 4.  An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022.

Authors:  Letizia Crocetti; Giuseppe Floresta; Agostino Cilibrizzi; Maria Paola Giovannoni
Journal:  Molecules       Date:  2022-08-04       Impact factor: 4.927

5.  Effects and mechanisms of action of sildenafil citrate in human chorionic arteries.

Authors:  Chrisen H Maharaj; Daniel O'Toole; Tadhg Lynch; John Carney; James Jarman; Brendan D Higgins; John J Morrison; John G Laffey
Journal:  Reprod Biol Endocrinol       Date:  2009-04-23       Impact factor: 5.211
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.